Related Experiment Video
Updated: Jun 25, 2026

05:15
Grossing of Non-neoplastic Globes, Including Fetal Eyes
Published on: May 30, 2025
Ocular teratogens: old acquaintances and new dangers
1Department of Ophthalmology, Kettering General Hospital, Edinburgh, UK. anamikatan@gmail.com
Eye (London, England)
|February 21, 2009
Summary
Animal studies reveal how teratogens like alcohol affect fetal brain and eye development. New research also examines risks of agents like benzodiazepines for ocular malformations.
Area of Science:
- Developmental toxicology
- Neuroscience
- Ophthalmology
Background:
- Teratogens are agents causing developmental abnormalities.
- Alcohol is a well-studied teratogen impacting fetal development.
- Understanding teratogenic mechanisms is crucial for preventing birth defects.
Purpose of the Study:
- To review current understanding of teratogen pathophysiology using animal models.
- To highlight advanced techniques for studying teratogenic effects on developing structures.
- To discuss emerging concerns regarding agents like benzodiazepines and fetal ocular development.
Main Methods:
- Review of existing animal study research on teratogens.
- Application of advanced imaging like positron emission tomography (PET).
- Analysis of retinal synaptogenesis in response to teratogenic exposure.
Main Results:
- Animal studies elucidate the pathophysiology of known teratogens like alcohol.
- PET and synaptogenesis studies identify specific brain and ocular targets of teratogens.
- Emerging data suggests potential ocular risks associated with benzodiazepine exposure in fetuses.
Conclusions:
- Animal research provides critical insights into teratogen-induced developmental abnormalities.
- Technological advancements aid in pinpointing teratogen-specific targets.
- Further investigation is warranted for newer agents like benzodiazepines concerning fetal ocular health.
Related Concept Videos
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Photoreceptors and Visual Pathways
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
